Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usageArticle Published on 2022-10-012022-11-15 Journal: Molecular biology reports [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Abstract binding domain Delta delta variant Neutralizing antibodies neutralizing antibody omicron Omicron variant receptor binding domain (RBD) SARS-CoV-2 SARS-COV-2 infection therapeutic [DOI] 10.1007/s11033-022-07493-z PMC 바로가기
Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 진단, [키워드] adjusted adverse effect age Analysis Anti-spike binding antibody unit binding domain boost Combination Complete Concentration COVID COVID-19 doses enrolled evaluated event female Frequency Gam-COVID-Vac Gender Heterologous Heterologous scheme homologous humoral humoral immune response IgG immunization increase individual induce interquartile range IQR Linear model median Mild moderate Moderna mRNA-1273 participant RBD real-world data required SARS-CoV-2 Serological assay Seven significantly significantly higher vaccination Vaccine [DOI] 10.1016/j.cmi.2022.05.009 PMC 바로가기
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infectionArticle Published on 2022-09-222022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] Antibody Response association baseline characteristics binding domain booster booster dose collected Comorbidity COVID-19 dose Factor hcp healthcare personnel Immunity Increased inverse correlation mRNA BNT162b2 vaccine mRNA vaccine NAb NAb titer NAb titers Neutralizing antibodies neutralizing antibody of BNT162b2 Sample SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor second dose serum sample study period tested vaccine dose women [DOI] 10.1016/j.vaccine.2022.08.031 PMC 바로가기
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipientsArticle Published on 2022-09-152022-11-15 Journal: Trials [Category] SARS, 진단, [키워드] 1:1 binding domain Booster vaccine cell-mediated response clinical Controlled trial COVID COVID-19 COVID-19 vaccination COVID-19 vaccine death develop disease severity dose Effectiveness Efficacy ENhance hospitalisation humoral hypothesise IgG immune cell population immunological Immunosuppression IMPROVE include increased risk Intervention kidney transplant recipient kidney transplant recipients Kidney transplantation live SARS-CoV-2 Modification mTOR inhibitor multicentre neutralisation New outcome participant Prednisolone Primary outcome proportion Protective protective immunity public health randomised randomised controlled trial Rapamycin recipient reduce reduced regimen registry responses SARS-CoV-2 SARS-CoV-2 vaccine secondary serological Sirolimus Standard of care Study protocol Tolerability Trial vaccination Vaccine vaccine response virus [DOI] 10.1186/s13063-022-06634-w PMC 바로가기
Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 InfectionArticle Published on 2022-09-042022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] acute respiratory syndrome antibodies antibody antibody course antibody half-life B-cell B-cells binding domain Concentration coronavirus coronavirus 2 correlated Course COVID-19 Evidence examined Frequency immune response Immunity indicate Infection Influenza virus MBC memory memory B-cell memory B-cells. Mild moderate question raise required respiratory response robust SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 NP antibody SARS-CoV-2 proteins SARS-CoV-2 RBD SARS-CoV-2 receptor SARS-CoV-2 spike protein subject vaccination virus Year [DOI] 10.1093/infdis/jiac034 PMC 바로가기
Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samplesArticle Published on 2022-09-022022-11-15 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] Antenatal anti-RBD antibody binding domain community transmission Critical death Deprivation determine Effect Estimated Evidence groups hospitalisation incidence London NHS Outbreaks pandemic peaked Prevalence quantified reflect resource risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor serum sample serum samples significant interaction tested the SARS-CoV-2 virus Transmission dynamics [DOI] 10.1371/journal.pone.0273966 PMC 바로가기
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancerObservational Study Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] activated adverse effects Antibody titers Atypical B cells binding domain Booster vaccine Cancer cancer patient Cancer patients Chemotherapy collected COVID-19 COVID-19 vaccination COVID-19 vaccine dose evaluate Follow-up Frequency healthy individual humoral inactivated Inactivated vaccine investigated MBC memory B cell memory B cells NAb NAbs neutralizing antibody old age Patient prospective observational study receiving risk factor Safe Safety SARS-CoV-2 vaccine serum serum antibody subpopulation [DOI] 10.1016/j.ijid.2022.07.050 PMC 바로가기 [Article Type] Observational Study
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population일본 인구에서 오미크론 변이체 중화에 대한 BNT162b2 백신 3차 접종의 효과Article Published on 2022-09-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] acquired immunity Anti-receptor binding domain antibody anti-SARS-CoV-2 antibody binding domain BNT162b2 BNT162b2 vaccine booster booster vaccination collected contribute COVID-19 case COVID-19 cases declines Delta dose Efficacy elevated evaluated event fatigue Fever healthcare worker Healthcare workers humoral Humoral immunity Immunity individual Japanese Local local swelling median myalgia neutralization Neutralizing Neutralizing activity neutralizing antibody of BNT162b2 omicron Omicron variant Pfizer promotion provide Pseudotyped viruses Questionnaires reduced SARS-CoV-2 second dose sera serum sample serum samples Side effect Side effects significantly swelling Toyama U/mL university vaccination Vaccine variant variants was measured Waves wild-type [DOI] 10.1016/j.jiac.2022.05.009 PMC 바로가기 [Article Type] Article
Longitudinal dynamics of SARS-CoV-2 anti-receptor binding domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccinationArticle Published on 2022-09-012022-11-15 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Analysis analyzed Anti-RBD antibody Anti-RBD IgG antibody binding antibody binding domain BNT162b2 BNT162b2 vaccine coronavirus decrease domain doses female female participant HCWs Health care Health care worker health care workers highest highlight Humoral response IgG antibody IgG level immune response Immunoglobulin longitudinal male quantitative assay RBD SARS-CoV-2 second dose Sex significant difference spike glycoprotein Support the RBD the S1 subunit the spike protein the vaccine These data vaccination Vaccines were measured [DOI] 10.1016/j.ijid.2022.05.061 PMC 바로가기
Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-EcuadorCOVID-19의 1.2~10.0개월 회복기 혈장 샘플에서 SARS-CoV-2에 대한 중화 활성: 키토-에콰도르에서 수행된 횡단 대리 시험관내 연구Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] absence acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition analyzed binding domain BSL2 facility BSL3 caused convalescence Convalescent patients convalescent plasma convalescent sera coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 determine diagnostic methods Ecuador glycoprotein IgG IgM Immunoglobulin Immunoglobulin G immunoglobulin M in some in vitro study Infection NAb NAbs neutralization test Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody performed plasma positive presence or absence Quito remained reported respiratory SARS-CoV-2 Seroconversion severe acute respiratory syndrome Coronavirus surrogate Test the SARS-CoV-2 Viral viral spike virus Wuhan Wuhan, China [DOI] 10.1002/jmv.27866 PMC 바로가기 [Article Type] Article